Introduction: Until now, there is no clinically approved specific medicine to treat COVID-19.
Prior systematic reviews (SRs) have shown that traditional Chinese medicine (TCM) reduces …

Since late 2019, the novel coronavirus SARS-CoV-2 has introduced a wide array of health
challenges globally. In addition to a complex acute presentation that can affect multiple …

Background: Integrative herbal medicine has been reported to have beneficial effects in the
treatment of coronavirus disease 2019 (COVID-19). Aim: To compile up-to-date evidence of …

The outbreak of 2019 novel coronavirus (COVID-19) has caused serious threat to public
health. Discovery of new anti-COVID-19 drugs is urgently needed. Fortunately, the crystal …

Introduction COVID-19 is severely affecting countries globally and mortality is high.
Xuebijing (XBJ) injection is widely used in the treatment of severe pneumonia and sepsis in …

Objectives: The outcomes reported in trials in coronavirus disease 2019 are extremely
heterogeneous and of uncertain patient relevance, limiting their applicability for clinical …

Background: Previous research suggested that Chinese Medicine (CM) Formula
Huashibaidu granule might shorten the disease course in coronavirus disease 2019 (COVID …

Many COS projects have been completed in critical care, with more on-going COS projects,
including foci from across the spectrum of acute critical care, COVID-19, critical care …

Abstract Objective Traditional Chinese medicine plays a significant role in the treatment of
the pandemic of coronavirus disease 2019 (COVID-19). Tanreqing Capsule (TRQC) was …

Abstract The coronavirus disease 2019 (COVID‐19) pandemic is ongoing and many drugs
have been studied in clinical trials. From a pathophysiological perspective, anti‐viral drugs …